Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Aug;8(8):827-32.
doi: 10.3201/eid0805.020014.

Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan

Po-Ren Hsueh  1 , Lee-Jene Teng, Cheng-Yi Chen, Wen-Hwei Chen, Chong-Jen Yu, Shen-Wu Ho, Kwen-Tay Luh
Affiliations

Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan

Po-Ren Hsueh et al. Emerg Infect Dis. 2002 Aug.

Abstract

The rapid emergence (from 0% before 1998 to 6.5% in 2000) of pandrug-resistant Acinetobacter baumannii (PDRAB) was noted in a university hospital in Taiwan. To understand the epidemiology of these isolates, we studied 203 PDRAB isolates, taken from January 1999 to April 2000: 199 from 73 hospitalized patients treated at different clinical settings in the hospital and 4 from environmental sites in an intensive-care unit. Pulsed-field gel electrophoresis analysis and random amplified polymorphic DNA (RAPD) generated by arbitrarily primed polymerase chain reaction of these 203 isolates showed 10 closely related genotypes (10 clones). One (clone 5), belonging to pulsotype E and RAPD pattern 5, predominated (64 isolates, mostly from patients in intensive care). Increasing use of carbapenems and ciprofloxacin (selective pressure) as well as clonal dissemination might have contributed to the wide spread of PDRAB in this hospital.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Annual consumption (gram/patient-day x 1,000) of carbapenems (imipenem and meropenem), extended-spectrum cephalosporins (cefotaxime, ceftroaxone, ceftazidime, and cefepime), ciprofloxacin, aminoglycosides (gentamicin, tobramycin, netilmicin, and amikacin) and percent of isolates of imipenem-resistant and pandrug-resistant Acinetobacter baumannii (PDRAB) at the National Taiwan University Hospital, 1993–2000.
Figure 2
Figure 2
(A) Ten pulsotypes obtained by pulsed-field gel electrophoresis (PFGE) after digestion with SmaI. Lane M, molecular size marker. Lanes A to J, pandrug-resistant Acinetobacter baumannii (PDRAB) isolates belonging to pulsotypes A to J, respectively. (B) Ten subtypes of pulsotype E. Lanes M, molecular size marker. Lane E1 to E10, PDRAB isolates belonging to subtypes E1 to E10, respectively.
Figure 3
Figure 3
Random amplified polymorphic DNA (RAPD) patterns generated by arbitrarily primed polymerase chain reaction for pandrug-resistant Acinetobacter baumannii (PDRAB) isolates using two primers OPA-05 (A) and OPA-02 (B). Lane M, molecular size marker. Lanes A to J, RAPD patterns 1 to 10. Isolates of PDRAB belonging to pulsotypes A to J exhibit RAPD pattern 1–10, respectively.
Figure 4
Figure 4
(A) Distribution of pulsed-field gel electrophoresis (PFGE) profiles (pulsotypes) of pandrug-resistant Acinetobacter baumannii (PDRAB) isolates, May 1998–April 2000. Number within each bar indicates number of isolates with pulsotype E (clone 5). Letter above indicated bar denotes isolates exhibiting pulsotype (s) other than pulsotype E. (B) Distribution of pulsotype E in seven intensive-care units (ICU-1 to ICU-7) and 13 general wards (GW). Number above each bar indicates number of isolates with pulsosubtype E2.
See this image and copyright information in PMC

References

    1. CDC NNIS System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued in 1999. Am J Infect Control. 1999;27:520–32. 10.1016/S0196-6553(99)70031-3 - DOI - PubMed
    1. Fridkin SK, Steward CD, Edwards JR. Surveillance of antimicrobial use and antimicrobial resistance in United States hospital: project ICARE phase 2. Clin Infect Dis. 1999;29:245–52. 10.1086/520193 - DOI - PubMed
    1. Hsueh PR, Liu YC, Yang D, Yan JJ, Wu TL, Huang WK, et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist. 2001;7:373–82. 10.1089/10766290152773383 - DOI - PubMed
    1. Hsueh PR, Chen ML, Sun CC, Chen WH, Pan HJ, Yang LS, et al. Emergence of antimicrobial drug resistance of major pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg Infect Dis. 2002;8:63–8. - PMC - PubMed
    1. Hsueh PR, Liu CY, Luh KT. Current status of antimicrobial resistance in Taiwan. Emerg Infect Dis. 2002;8:132–7. - PMC - PubMed

MeSH terms

Substances